Hexaxim (DTaP-IPV-Hep B-Hib vaccine) / Sanofi 
Welcome,         Profile    Billing    Logout  

6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hexaxim (DTaP-IPV-Hep B-Hib vaccine) / Sanofi
2017-004069-29: Study to Describe Persistence of Hepatitis B Antibodies in Children Vaccinated with a Hexavalent Vaccine and to Evaluate Their Immune Memory Following a Vaccination with Hepatitis B Vaccine

Ongoing
4
487
Europe
Engerix B, Suspension for injection in pre-filled syringe, Engerix B
Sanofi Pasteur, Sanofi Pasteur
challenge dose of Engerix B to assess the quality of the persisting immune memory against hepatitis B in children aged 6 to 7 years, challenge dose of Engerix B to assess the quality of the persisting immune memory against hepatitis B in children aged 6 to 7 years, Diseases [C] - Bacterial Infections and Mycoses [C01]
 
 
2018-004581-34: Evaluate the efficacy and safety la vacuna hexavalente (Hexyon) in preterm infants Evaluar la eficacia y seguridad de la vacuna hexavalente (Hexyon) en recién nacidos prematuros

Not yet recruiting
4
140
Europe
Hexyon, Suspension for injection in pre-filled syringe, Hexyon®
Fundación Instituto Hispalense de Pediatría, SANOFI
Vaccines, Bacterial and viral vaccines combined Vacunas, vacunas bacterianas y virales combinadas., Vaccines Vacunas, Diseases [C] - Virus Diseases [C02]
 
 
2019-002585-12: Study to Assess the Immune Response and the Safety Profile of DTaP-IPVHB- PRP~T Combined Vaccine Given Concomitantly or Sequentially with 4CMenB Vaccine in Italian Infants Studio per valutare la risposta immunitaria e il profilo di sicurezza del vaccino combinato DTaP-IPVHB- PRP ~ T somministrato in concomitanza o in sequenza con il vaccino 4CMenB in infanti italiani

Ongoing
4
396
Europe
NA, [NA], Suspension for injection, Suspension for injection in pre-filled syringe, Hexyon sospensione iniettabile - vaccino coniugato (adsorbito) contro difterite, tetano, pertosse (componente acellulare), epatite B (rDNA), poliomielite (inattivato) ed Haemophilus influenzae di tipo b, Bexsero sospensione iniettabile in siringa preriempita - Vaccino contro il meningococco di gruppo B (rDNA, componente, adsorbito), Prevenar 13 sospensione iniettabile - Vaccino pneumococcico polisaccaridico coniugato (13 valente adsorbito)
SANOFI PASTEUR, Sanofi Pasteur, Sanofi Pasteur
Haemophilus influenzae type b immunisation Immunizzazione Haemophilus influenzae di tipo B, Active immunization against diphtheriae, tetanus, pertussis, hepatitis B, poliomyelitis & invasive infections caused by Haemophilus influenzae type b Immunizzazione attiva contro difterite, tetano, pertosse, epatite B, poliomielite e infezioni invasive causate da Haemophilus influenzae di tipo b, Diseases [C] - Virus Diseases [C02]
 
 
NCT02821195: Study of Sanofi Pasteur's DTaP-IPV Hep B-PRP-T Combined Vaccine in Infants Who Previously Received Hepatitis B Vaccine

Recruiting
3
354
RoW
DTaP-IPV-Hep B-PRP-T combined vaccine, Hexaxim™
National Institute of Hygiene and Epidemiology, Vietnam, Sanofi Pasteur, a Sanofi Company
Diphtheria, Tetanus, Pertussis, Poliomyelitis, Hepatitis B, Haemophilus Influenzae Type b Infection
12/16
03/17
NCT03547271 / 2017-004731-36: Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe

Hourglass Jan 2023 - Dec 2023 : Data from trial for meningococcal infections
Completed
3
1660
Europe, RoW
MenACYW conjugate vaccine, MenQuadfi®, Meningococcal group A, C, W-135, and Y conjugate vaccine, Nimenrix®, DTaP-IPV-HB-Hib vaccine, Hexyon®/Hexacima®, Pneumococcal vaccine (13-valent), Prevenar 13®, Pneumococcal vaccine (10-valent), Synflorix®, MMR vaccine, M-M-RVAXPRO®
Sanofi Pasteur, a Sanofi Company
Meningococcal Infections
05/23
05/23
MEQ00064, NCT05794230: Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa

Recruiting
3
1528
RoW
Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine, MenACYW conjugate vaccine - MenQuadfi™, Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Menactra®, Oral bivalent types 1 and 3; Poliomyelitis Vaccine (OPV), BIOPOLIO® B1/3, Pneumoccocal Vaccine, Prevnar 13®, Measles, Mumps, and Rubella Vaccine live (MMR) - TRESIVAC®, TRESIVAC®, DTwP-HepB-Hib-IPV vaccine, EasySix™, DTaP-IPV-Hib-HepB vaccine, Hexaxim®, Hepatitis A vaccine - HAPIBEV™, HAPIBEV™, Rotavirus vaccine, RotaTeq®, Typhoid conjugate vaccine (TCV), Typbar TCV®, Measles vaccine - MeasBio®, MeasBio®, Varicella vaccine live - VARIPED®, VARIPED®, Varicella vaccine live - Onvara, Onvara, Measles, Mumps, and Rubella Vaccine live (MMR) - OMZYTA®, OMZYTA®, Hepatitis A vaccine - Avaxim 80 U, Avaxim 80 U
Sanofi Pasteur, a Sanofi Company
Meningococcal Immunisation, Healthy Volunteers
09/25
09/25

Download Options